A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4
Clinical trial NCT06246513 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06246513
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-15
- Primary completion
- 2025-03-04
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.